Headache disorders are the most frequent brain conditions among the general population affecting the majority of people. IHA (Iranian Headache Association), a national, nonprofit organization that supervised by Iranian neurological association , has sought to improve the life of those affected by headache in Iran. IHA dedicates its efforts to changing of information and ideas concerning the causes and treatments of headache and related painful disorders. Teaching of key players such as neurologists, general practitioners and all those involved in headache management about the diagnosis and treatment of headache disorders is focused. We thank you for your interest in IHA! Please be sure to visit the many sections of our website to learn more about headache, and find out how you can be a part of our important mission of improving lives today.

Medical Intelligence

Challenge Yourself, Build Your Knowledge


6th International Iraninan Headache Congress

Abstract Submission is now open

Lasmiditan for acute treatment of migraine

FDA Approves New Drug Option for Acute Migraine please click here to see the FDA approval for lasmiditan

Recent News


Galcanezumab (Emgality) Gets FDA OK for Cluster Headache

Galcanezumab (Emgality) Gets FDA OK for Cluster Headache Megan Brooks June 04, 2019 The US Food and Drug Administration (FDA) has approved… Read More →

The 6th Iranian International Headache Congress

Abstract Submission is now open For submitting your abstract, click Here…. Read More →

Back to Top